Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves Β· freshest Wall Street data, updated daily View live feed β†’
Analyst Tracker/Olivia Brayer
CANT

Olivia Brayer

Wall Street Analyst
β˜…β˜†β˜†β˜†β˜†
#2936
on 13Foresight Β· ranked by our own returns
40%
Success Rate
-4.8%
Average Return
18 of 45 calls profitable Β· -11.0% vs benchmark
S&P 500 (SPY)
πŸ”’ 5-year track record is Pro. Showing 1-year β€” upgrade.
πŸ“ˆ Across the calls we could measure, roughly 40% of Olivia Brayer's ratings turned a profit when each position was held for 1 year β€” averaging -4.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

41 Buy 3 Hold 0 Sell
Olivia's Stock Coverage 25 ratings Β· 2026-11-17
Company Date Position Consensus β“˜ Price Target β“˜ 1-Yr Return vs S&P 500 β“˜
VNDA
Vanda
Oct 28, 2026 BUY Strong Buy
+411.2% avg upside
13 analysts
$11.00
190.14% Upside
-4.8% Β·
UTHR
United Therapeutics
Oct 26, 2026 BUY Buy
-22.7% avg upside
27 analysts
$850.00
42.02% Upside
-1.5% Β·
ENSC
Ensysce Biosciences
Oct 20, 2026 BUY Buy
+1919.0% avg upside
4 analysts
$2.00
375.11% Upside
-17.8% Β·
BMRN
BioMarin Pharmaceutical
Oct 19, 2026 BUY Strong Buy
+63.6% avg upside
52 analysts
$86.00
47.04% Upside
+7.0% Β·
BRVE
Braveheart Bio, Inc.
Oct 19, 2026 BUY Strong Buy
+95.4% avg upside
5 analysts
$40.00
85.92% Upside
-2.2% Β·
MNKD
MannKind
Oct 19, 2026 BUY Buy
+104.0% avg upside
22 analysts
$8.00
128.49% Upside
+31.7% Β·
OMER
Omeros
Oct 14, 2026 BUY Buy
+13.6% avg upside
14 analysts
$22.00
19.35% Upside
-24.5% Β·
CTMX
CytomX Therapeutics
Oct 13, 2026 BUY Strong Buy
+361.2% avg upside
21 analysts
$12.00
412.86% Upside
-16.7% Β·
ALNY
Alnylam Pharma
Sep 30, 2026 HOLD Strong Buy
+76.3% avg upside
53 analysts
$325.00
97.03% Upside
-36.6% Β·
TENX
Tenax Therapeutics
Sep 09, 2026 BUY Strong Buy
+1239.3% avg upside
9 analysts
$35.00
1855.24% Upside
-30.5% Β·
MIST
Milestone Pharmaceuticals
Aug 20, 2026 BUY Strong Buy
+910.2% avg upside
8 analysts
$3.00
310.96% Upside
-59.9% Β·
IRLA
IRulya Therapeutics
Aug 17, 2026 BUY Buy
+434.4% avg upside
19 analysts
$70.00
112.45% Upside
+16.7% Β·
INSM
Insmed
Aug 06, 2026 BUY Strong Buy
+51.3% avg upside
37 analysts
$235.00
108.80% Upside
-8.1% Β·
CNTB
Connect Biopharma Holdings
May 21, 2026 BUY Strong Buy
+718.8% avg upside
12 analysts
$4.00
398.72% Upside
-75.5% Β·
IKT
Inhibikase Therapeutics
May 18, 2026 BUY Strong Buy
+252.8% avg upside
9 analysts
$4.00
158.15% Upside
-14.3% Β·
PTHS
Pelthos Therapeutics
Apr 01, 2026 BUY Strong Buy
+396.4% avg upside
8 analysts
$50.00
431.93% Upside
-67.9% Β·
GOSS
Gossamer Bio
Mar 20, 2026 HOLD Buy
+1287.3% avg upside
17 analysts
β€” Β· Β·
VRTX
Vertex Pharmaceuticals
Feb 11, 2025 BUY Strong Buy
-20.5% avg upside
62 analysts
$480.00
14.11% Downside
+1.3% Β·
AMGN
Amgen
Feb 05, 2025 BUY Buy
-29.9% avg upside
57 analysts
$340.00
27.04% Downside
+23.4% Β·
BMY
Bristol-Myers Squibb
Feb 04, 2025 HOLD Buy
-2.2% avg upside
42 analysts
$55.00
11.95% Downside
+2.4% Β·
GILD
Gilead Sciences
Nov 06, 2024 HOLD Strong Buy
-27.3% avg upside
66 analysts
$80.00
53.09% Downside
+38.6% Β·
REGN
Regeneron
Apr 17, 2024 HOLD Strong Buy
-12.2% avg upside
60 analysts
$925.00
0.41% Downside
-37.4% Β·
AUPH
Aurinia Pharmaceuticals
Feb 23, 2024 BUY Strong Buy
-4.6% avg upside
12 analysts
$10.00
40.00% Downside
+33.3% Β·
CRSP
Crispr Therapeutics AG
Oct 17, 2023 HOLD Buy
+45.6% avg upside
41 analysts
β€” +10.6% Β·
LENZ
LENZ Therapeutics
Mar 20, 2023 HOLD Buy
+470.0% avg upside
17 analysts
$3.00
1.68% Downside
+91.1% Β·
πŸ”’ 20 more ratings β€” with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Olivia Brayer β€” Frequently Asked Questions
How accurate are Olivia Brayer's stock ratings?
Based on the calls 13Foresight could measure, about 40% of Olivia's ratings were profitable over a one-year hold, with an average return of -4.7% per rating, or -10.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Olivia ranked on 13Foresight?
Olivia Brayer is currently ranked #2936 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge β€” so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Olivia cover?
Olivia most recently has ratings on VNDA, UTHR, ENSC, BMRN, BRVE, MNKD, OMER, CTMX, ALNY, TENX, MIST, IRLA and 13 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.